Shares of Inovio Pharmaceuticals slid 7.84% to $11.87 at 11:20 EST on Tuesday, after two sequential sessions in a row of gains. NASDAQ Composite is dropping 1.72% to $13,300.74, following last session’s downward trend, This seems, up until now, an all-around negative trend trading session today.

Inovio Pharmaceuticals’s last close was $13.87, 184.67% below its 52-week high of $33.79.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is 297.8% for the present quarter and a decline by 50.3% for the next. The company’s growth estimates for the present quarter and the next is 42.1% and 30.8%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 72.8%, now sitting on 2.11M for the twelve trailing months.


Inovio Pharmaceuticals’s last day, last week, and last month’s average volatility was 8.02%, 8.30%, and 7.93%, respectively.

Inovio Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 13.89%, 17.74%, and 13.10%, respectively.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $11.87 at 11:20 EST, way under its 52-week high of $33.79 and way above its 52-week low of $3.57.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s worth is higher than its 50-day moving average of $11.36 and under its 200-day moving average of $12.18.


Please enter your comment!
Please enter your name here